Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-015940
Filing Date
2023-04-28
Accepted
2023-04-28 17:02:45
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS print_janx_10-k_2022.pdf ARS 11212860
  Complete submission text file 0000950170-23-015940.txt   15445555
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40475 | Film No.: 23867986
SIC: 2834 Pharmaceutical Preparations